NewsBenzinga리사타 테라퓨틱스, 주주들의 최대 350,498,987주 보통주 재판매 관련 증권신고서 제출 리사타 테라퓨틱스, 주주들의 최대 350,498,987주 보통주 재판매 관련 증권신고서 제출 Benzinga 2026.11.12 22:22 (GMT+0) Open on Benzinga Other news From AI Chips to Rocket Ships: Will Jensen Huang Join Elon Musk? AOC Says Five Guys in Tuxedos Shouldn’t Control the Economy: ‘We Need to Check These Guys Power’ Here's How Much $100 Invested In Imperial Oil 5 Years Ago Would Be Worth Today LGL Group Q3 Sales $1.464M Miss $1.900M Estimate AmpliTech Group FY2026 Revenue expected to be more than $28.000M vs $36.400M Est Lisata Therapeutics Files Prospectus Related To The Resale Of Up To 350,498,987 Common Shares By Selling Stockholders
Lisata Therapeutics Files Prospectus Related To The Resale Of Up To 350,498,987 Common Shares By Selling Stockholders
